AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06358365 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The AquaPass System
Description: The system is a non-invasive, renal-independent, single-patient, multiple-use device intended for use at the hospital, outpatient clinic, or home. The system administers warm, dry air around the patient's body to create an environmental condition that activates the eccrine glands to produce sweat, in return it removes fluids from the interstitial compartment, where fluids accumulate in fluid overload.
Study NCT06175299 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adherence Promotion With Person-centered Technology (APPT) System with Social Functions
Description: The system has seven games for cognitive training and two social interactions functions: a chat function and a leaderboard function.
Study NCT05240300 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BX005-A
Description: phage gel
Study NCT05837936 — intervention group
Intervention type: OTHER
Intervention: Sevoflurane initiated intravenous anesthesia (SIIVA)
Description: SIIVA - sevoflurane anesthetic gases for surgery
Study NCT05240300 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: vehicle gel
Study NCT05323032 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multifocal electroretinogram (mf-ERG) by electroretinogram device
Description: Measurement of mf-ERG parameters with 61 stimulus elements to asses amplitude of waves in nano volt/degree square (nv/deg2) and latency in millisecond (msec) as measured by electroretinogram device.
Study NCT05891132 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 10 ml of lidocaine 2%
Description: 10 ml of lidocaine 2% for perineal infiltration at the time of crowning
Study NCT05891132 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: lidocaine prilocaine cream 15gm
Description: Lidocaine prilocaine cream, an eutectic mixture, is composed of Lidocaine-25 mg, Prilocaine-25 mg, Arlactone 289 -19 mg, Carbopol-10 mg, Sodium hydroxide to make a pH of 9.6 mg and purified water to produce l gram.
Study NCT06548412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Given by IV
Study NCT06364852 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY007
Description: FC and LY007 infusion
Study NCT05010200 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CDX-301
Description: soluble recombinant human protein to work on stem cell
Study NCT06368505 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ultrasound guided PRP injection
Description: whole blood is initially collected in tubes that contain anticoagulants, such as citrate dextrose A to prevent platelet activation prior to its use. Then PRP is prepared by a differential centrifugation. Then 3ml of PRP will be delivered via the in-plane ulnar approach
Study NCT06368505 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ultrasound guided hydrodissection
Description: 5ml will be injected to detach the median nerve from the TCL (2ml saline, 2ml dexamethasone and 1ml lidocaine), the injectate will be delivered via the in-plane ulnar approach, and the median nerve will be hydrodissected from its undersurface while advancing the needle among the superficial surface of the median nerve and the TCL
Study NCT05664659 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin + misoprostol
Description: 600 micrograms misoprostol rectally 20 IU Oxytocin IV infusion on 1000 ml of normal saline solution
Study NCT05664659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbetocin
Description: 100 micrograms carbetocin
Study NCT06548412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given by IV
Study NCT06548412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Given by IV
Study NCT06548412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CTX-009
Description: Given by IV
Study NCT05739175 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile Application with Interactive Nurse Support
Description: A mobile application containing an interactive nurse support program will be applied to the patients in the experimental group and its effect on patient outcomes will be evaluated through scales.~The mobile application consists of three modules. The first part is a learning module with videos on Covid 19, breast cancer and chemotherapy related side effects management. Second part is ask the nurse/doctor. Third part is patient experiences module.~After the participants download the mobile application to their phones, they can log in to the application with a valid e-mail address and password.
Study NCT06192134 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPM device
Description: CPM brace
Study NCT05706623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apraglutide
Description: Single dose of apraglutide 5mg.
Study NCT05433805 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fasting-mimicking diet (FMD) and physiotherapy
Description: FMD is a diet held monthly during five days with the restriction of calories to less than 1000 kcal, glucose and proteins.~Physiotherapy will be organized as home-based exercises explained by the physiotherapeutist at the beginning of the study.
Study NCT04810975 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Muscle Strength Training
Description: Strength training occurring specific exercise regimens using Exercise Equipment A or B
Study NCT04929106 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mHealth support tool
Description: The final app is named Active Leisure and consists of an advanced activity planner based on the platform developed by the ideal company Smart Cognition AS. The app offers different interface options (symbols only, easy to read text, plain text, and read aloud). The activity planner will mostly be used by the individual with IDs and a support person (caregiver or health care provider). After completing an activity, a simple reward is available (e.g., a smiling face or to share a picture with other users of the app). The use of tailored communication through personalization: the use of individuals first name in the activity planner, adaptation: individually chosen activities, adjusted communication (symbols, easy-to-read text or plain text), preparation and planning, and feedback: rewarding and positive feedback (after activities have been performed) is expected to increase motivation, and thereby lead to higher levels of PA.
Study NCT06778824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Takepron
Description: Participants are expected to take a proton-pump inhibitor (PPI) for 12 weeks, with a dosage of 30 mg taken once a day.
Study NCT06778824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zoloft 50Mg Tablet
Description: Participants are expected to take a selective serotonin reuptake inhibitor (SSRI) for 12 weeks, with a dosage of 50 mg taken once a day.
Study NCT06778824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imipramine Pill
Description: Participants are expected to take tricyclic antidepressants (TCA) for 12 weeks, with a dosage of 25 mg taken twice a day.
Study NCT06162377 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylnaltrexone
Description: Given by SC (injection)
Study NCT05952024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Description: Patients will receive acalabrutinib orally with dosing schedule of X.
Study NCT05952024 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Patients will receive rituximab via IV infusion on Cycle 1 Day 15 and via SC injection on Day 1 of Cycle 2 through Cycle 8.
Study NCT04176965 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FINEVISION HP IOL
Description: Cataractous lens will be removed in the study eyes and the FINEVISION HP IOL will be implanted in the capsular bag.
Study NCT04176965 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Alcon AcrySof SN60AT
Description: Cataractous lens will be removed in the study eyes and the Alcon AcrySof SN60AT IOL will be implanted in the capsular bag.
Study NCT04868110 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High fiber diet
Description: A registered dietitian will delivered the lessons on consuming a high fiber diet to small groups to increased engage and material retention. These lessons will last 18 weeks.
Study NCT06797492 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Shoulder Physical Examination
Description: shoulder physical examination is conducted to assess the patient's musculoskeletal condition and to track progress throughout the rehabilitation phases
Study NCT06797492 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Shoulder Rehabilitation in a Virtual Environment
Description: The rehabilitation protocol for shoulder disorders is executed using a Virtual Reality (VR) system, where patients perform customized exercises tailored to their physical characteristics.
Study NCT06797492 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usability assessment and presence and co-presence evaluation
Description: The usability of the VR system, along with the sense of presence and co-presence during rehabilitation, is assessed using validated scales
Study NCT06795789 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitals+ (combined multivitamin and polyphenol supplement)
Description: Multivitamin with 19 essential nutrients combined with Bilberry polyphenols
Study NCT06794840 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: JomCare is a smartphone-based just-in-time adaptive intervention (JITAI) for chemsex-related harm reduction.
Description: JomCare is a smartphone-based just-in-time adaptive intervention (JITAI) that uses an EMA-based machine learning (ML) algorithm to anticipate chemsex risk and deliver appropriate chemsex-related harm reduction and HIV prevention services when the risk is detected.
Study NCT06794840 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: JomCare is a smartphone-based just-in-time adaptive intervention (JITAI) for chemsex-related harm reduction.
Description: JomCare is a smartphone-based just-in-time adaptive intervention (JITAI) that uses an EMA-based machine learning (ML) algorithm to anticipate chemsex risk and deliver appropriate chemsex-related harm reduction and HIV prevention services when the risk is detected.
Study NCT06796140 — intervention group
Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zone - Left hemi-back
Description: The treated zone located on the left side of the hemi-back was exposed to Visible Light with the simulator 1 to induce skin pigmentation (144J/cm2), 15 to 30 minutes after application.
Study NCT06796140 — intervention group
Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zone - Right hemi-back
Description: The treated zone located on the right side of the hemi-back was exposed to Visible Light with the simulator 2 to induce skin pigmentation (144J/cm2), 15 to 30 minutes after application.
Study NCT06796140 — intervention group
Intervention type: OTHER
Intervention: Visible Light Exposure - Untreated zone - Left hemi-back
Description: The untreated zone located on the left side of the hemi-back was exposed to Visible Light with the simulator 1 to induce skin pigmentation (144J/cm2), as the same time as the treated zone.
Study NCT06796140 — intervention group
Intervention type: OTHER
Intervention: Visible Light Exposure - Untreated zone - Right hemi-back
Description: The untreated zone located on the right side of the hemi-back was exposed to Visible Light with the simulator 2 to induce skin pigmentation (144J/cm2), as the same time as the treated zone.
Study NCT06793865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Russian Current Stimulation for Anterior Tibial Group
Description: Parameters were adjusted as the following frequency of 2.5 kHz and 50 bursts per second with 50 pulses per burst. The stimulus was applied for a 10 seconds on period followed by a 10 seconds off period for total treatment time 20 minutes.
Study NCT06793865 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Russian Current Stimulation for Anterior Tibial Group
Description: Placebo Russian current stimulation was applied to the anterior tibial group without active current for 20 minutes.
Study NCT06793865 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Selected physical therapy exercise for both limbs
Description: The selected physical therapy exercise for both limbs was applied for 40 minutes, including passive, active assisted and active range of motion exercises, stretching of spastic muscles, strengthening of weak muscles (anterior tibial group), and finally functional mobility exercises.
Study NCT06793865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Selected physical therapy exercise for both limbs
Description: The selected physical therapy exercise for both limbs was applied for 40 minutes, including passive, active assisted and active range of motion exercises, stretching of spastic muscles, strengthening of weak muscles (anterior tibial group), and finally functional mobility exercises.
Study NCT06793280 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: intraoperative ICG angiography
Description: Intraoperative ICG angiography to evaluate colonic perfusion
Study NCT06793280 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: No intraoperative ICG angiography
Description: Visual evaluation of colonic perfusion
Study NCT06794476 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Milieu Teaching-AV
Description: In Milieu Teaching-AV, coaches will teach caregivers to engage the child in play or routines around a standardized set of toys, follow the child's attention or communication lead around these toys, and respond to the infant's communication acts by modeling and expanding those communication acts into more sophisticated strategies. While responding to infant communication acts, coaches will slowly move the referent of the infant's lead near the face at approximately the level of the mouth, wait for the infant to shift his/her gaze towards the new referent position if necessary, and provide all models, prompting, and expanding while maintaining placement of the referent near the mouth.
Study NCT06792929 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality glasses group
Description: Patients will wear virtual reality glasses throughout the ultrasound-guided fine needle aspiration biopsy procedure.
Study NCT06793631 — intervention group
Intervention type: OTHER
Intervention: Participants will be interviewed qualitatively about experience of providing/receiving financial support for living costs
Description: There is no intervention for participants. Participants will receive qualitative interviews to explore their experience of financial insecurity
Study NCT06796166 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AI-Supported Preoperative Education
Description: This intervention involves the use of a pre-trained AI-powered education platform designed to provide preoperative information to patients undergoing mastectomy. The program delivers structured, interactive education that includes details about the surgical process, postoperative care, and emotional coping strategies. The pre-trained AI system offers standardized responses to patient questions, ensuring consistency and clarity in the information provided, with the goal of reducing fear and anxiety.
Study NCT06796166 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Preoperative Education
Description: This intervention consists of standard preoperative education provided by healthcare professionals. Patients receive general information about the surgical procedure, postoperative care, and strategies to manage fear and anxiety. The education is delivered in a traditional, face-to-face format without the use of AI or digital tools.
Study NCT06792760 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: The intervention will consist of 10 individual physiotherapy sessions delivered by a single physiotherapist trained in FMD. The physiotherapy programme will include education, movement retraining and a self-management plan.
Study NCT06792760 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: The intervention will consist of 10 individual physiotherapy sessions delivered by a single physiotherapist trained in FMD. The physiotherapy programme will include education, movement retraining and a self-management plan.
Study NCT06792760 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specific Breathing Techniques
Description: The intervention will include education and training in specific breathing techniques, which will be exercised by the patient as a self-management plan for over 5-10 minutes daily.
Study NCT06794762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional exercises
Description: Aerobic exercise and stretching exercises will be applied in the conventional exercise program.~A 20-30 minute walking will be done as aerobic exercise. Stretching exercises will be done for major muscle groups in 3 sets and 10 repetitions.
Study NCT06794762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization exercises in addition to conventional exercises
Description: In addition to the conventional exercise program, core stabilization exercises will be applied. During the exercises, participants will be trained on neutralizing the spine and working the transverse abdominis and multifidus muscles, correct postural control, and performing the exercises with diaphragmatic breathing.
Study NCT05237531 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized Preoperative Education
Description: The standardized preoperative education includes a brief video, an interactive quiz, and a written handout.~The video will provide information on the proper use and common side effects of opioid pain medications, the expected effects of a peripheral nerve block, and the concept of multimodal postoperative pain management with non-opioid medications and non-pharmaceutical pain management strategies. The interactive quiz will reinforce the critical components of the video in a question-and-answer format which requires active participation. The written handout will summarize the educational content in a form which can be easily referenced by patients at home.
Study NCT05237531 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Education per provider preference (no standardization, current standard of care)
Study NCT05237531 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative and postoperative questionnaires
Description: Preoperative questionnaire: Demographic questions plus specific questions about chronic pain, prior opioid use, and mental health diagnoses Postoperative questionnaire: Questions about pain control after surgery, satisfaction with pain control, healthcare contact since surgery, opioid consumption since surgery, and satisfaction with education
Study NCT05237531 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative questionnaires
Description: Preoperative questionnaire: Demographic questions plus specific questions about chronic pain, prior opioid use, and mental health diagnoses Postoperative questionnaire: Questions about pain control after surgery, satisfaction with pain control, healthcare contact since surgery, opioid consumption since surgery, and satisfaction with education
Study NCT06795776 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eschscholzia tablets
Description: The intervention will be provided as swallowable Eschscholzia tablets (1.0 g) containing 0.503g Eschscholzia californica Herba rec. tinct. conc. as the active pharmaceutical ingredient (API) corresponding 600 mg powdered herbal material.
Study NCT06795776 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Tablets
Description: A placebo tablet will be provided that matches the verum in its optical and sensorial properties and posology. Contains: microcrystalline cellulose, Colloidal anhydrous silica, glycerol distearate, caramel couleur and colorants.
Study NCT06797076 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health enSuite Headache
Description: The program consists of treatment modules delivered over 8 weeks. Modules include topics such as Headaches and Triggers, Relaxation, Breathing, Changing Thoughts, Imagery, Problem Solving, Nutrition, Sleep, Exercise, Medication, and more. Each module features sections like Goals, Getting Started, Let's Talk, and a Quiz, with Let's Practice in four modules. Intervention participants track headaches using a structured tracker to log impacts, daily events (e.g., exposure, strategies, medication), and notes. Control group participants track headaches only at baseline, two months, and five months post-randomization. Weekly reminders (nudges) encourage app usage, with the same frequency for all users. Reports summarizing daily headache data are available to participants and healthcare providers.
Study NCT03243058 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ILT-101 (Aldesleukin; IL-2)
Description: Administration of Low-Dose Interleukin-2 (ILT-101) for two years
Study NCT03243058 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ILT-101 (Aldesleukin; IL-2)
Description: Administration of Low-Dose Interleukin-2 (ILT-101) for two years
Study NCT03243058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment-Placebo Arm
Description: Administration of Low-Dose Interleukin-2 (ILT-101) for one year, and then placebo for the second year.
Study NCT03243058 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Arm
Description: Participants in this group will receive a placebo injection for two years.
Study NCT06030700 — intervention group
Intervention type: OTHER
Intervention: Controlled Conditions
Description: Use of FoodImage app to take pictures of food and/or receipts.